Optiscan Imaging Ltd
  • Home
  • Company
    • About Us
    • People
    • Network
    • Careers
    • Sustainability
    • Compliance
    • FAQ
  • Portfolio
    • Portfolio
    • Technology
    • Products
      • InVue
      • InForm
      • InVivage
      • ViewnVivo
      • InSpecta
    • Pipeline
    • Publications
    • Image Gallery
    • Webinars
    • FAQ
  • Investor
    • Investor Overview
    • ASX Announcements
    • Financial Reports
    • Share Price Information
    • Investor Relations
    • Investor Alerts
    • Entitlement Prospectus
  • News
    • News
    • Blog
    • Events
  • Contact
    • Contact

Select Category

  • Clinical Research
    • Oral cancer diagnosis and surgical margin
    • Brain cancer
    • General surgery
    • Cervical assessment
    • Gastrointestinal assessment
  • Life Sciences Research
    • Cell viability
    • Live antibody labelling
    • Intraoperative surgery and tumour margin delineation
    • Blood vessel, perfusion, and barrier function
    • Live microflora imaging
    • Nano particle and drug delivery
    • Proof of concept in live models

Recent Posts

  • Optiscan investor webinar - December 2025
  • Optiscan in the news - Landmark study to use Optiscan’s imaging tech in head and neck cancer surgery
  • Optiscan in the news - Who’s Who with Optiscan: The next leap in real-time medical imaging
  • Optiscan in the news - Optiscan lifts on milestone deal with Australian Clinical Labs
  • Optiscan in the news - Optiscan and Australian Clinical Labs partner to accelerate digital pathology innovation

Archives

  • December 2025
  • November 2025
  • October 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • November 2022
  • September 2022
  • February 2022
  • May 2021
  • March 2021
  • January 2021
  • December 2020

Categories

  • Announcements
  • Blogs
  • Blood vessel, perfusion, and barrier function
  • Brain cancer
  • Broker Research
  • Cell viability
  • Cervical assessment
  • Gastrointestinal assessment
  • General surgery
  • Intraoperative surgery and tumour margin delineation
  • Live antibody labelling
  • Live microflora imaging
  • Nano particle and drug delivery
  • Optiscan news
  • Oral cancer diagnosis and surgical margin
  • Proof of concept in live models
  • Uncategorized
  • Veterinary

Veterinary

24-May-2023 by
Read More
  • 1
Back to All Publications


Optiscan Logo

Acknowledgement of Country
Optiscan Imaging acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land on which we work and live. We offer respects to Elders past, present and emerging.

Quick Links

Follow Us

Contact Us

Stay Connected

Register Your Interest

Subscribe to Investor Alerts

Follow Us

Copyright © Optiscan Imaging Ltd
Site Map Search Terms of Use Privacy Policy Cookies Policy
Site by